Product Code: GQX FDA class 2 21 CFR 866.3900

Antiserum, Cf, Varicella-Zoster

Microbiology

The Antiserum, CF, Varicella-Zoster is a complement fixation antiserum used as a laboratory reagent to assist in serological detection of varicella-zoster virus (VZV) antibodies. As an FDA Class 2 device, it presents moderate risk and requires a 510(k) premarket notification to demonstrate substantial equivalence before marketing. Regulated under 21 CFR 866.3900 with product code GQX in the Microbiology specialty. This device is eligible for third-party 510(k) review.

510(k)s
11
FEI Numbers
2
Registration Numbers
2
Unique Applicants
9
Years Active
19

Research product code GQX in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
GQX
Device Class
FDA class 2
Regulation Number
866.3900
Medical Specialty
Microbiology
Review Panel
MI
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 11 510(k) clearances via K numbers.

K Number Device Name
K951799 VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY
K911301 VZV IGM TEST
K883427 VIRGO(R) VZV-IGG ELISA
K875358 VZV TEST
K863317 ENZYGNOST ANTI-VZV IGG TEST
K853540 FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGY
K852930 VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO
K842096 GLB VARICELLA-ZOSTER VIRUS FLUORESCENT
K841526 ORTHO VARICELLA-ZOSTER VIRUS IDENT.
K770810 VARICELLA-ZOSTER FA LABELED PRESERUM
K770806 VARICELLA-ZOSTER FA LABELLED (8-321 RF)

FEI Numbers

This FDA classification entry is associated with 2 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 2 registration numbers. Click on an entry to view related FDA registrations.